Please enable Javascript
Expert Interviews on RLT-PSMA
Utility of PSMA-PET in Intermediate Risk Prostate Cancer: Part 2
Daniel Tennenbaum, MD
RLT
|
December 1, 2022
Neil Desal, MD, MHS, is interviewed by Daniel Tennenbaum, MD, on the use of PSMA-PET in intermediate risk prostate cancer.
View More
Utility of PSMA-PET in Intermediate Risk Prostate Cancer: Part 1
Daniel Tennenbaum, MD
RLT
|
December 1, 2022
Neil Desal, MD, MHS, is interviewed by Daniel Tennenbaum, MD, on the use of PSMA-PET in intermediate risk prostate cancer.
View More
Clinical Utility of PSMA Imaging in the Initial Staging and Use in Surgical Planning: Part 2
David Ambinder, MD
Video Insights
|
December 1, 2022
An interview with Preston Sprenkle, MD, Associate Professor of Urology at Yale, on the clinical utility of PSMA imaging.
View More
Clinical Utility of PSMA Imaging in the Initial Staging and Use in Surgical Planning: Part 1
David Ambinder, MD
Video Insights
|
December 1, 2022
An interview with Preston Sprenkle, MD, Associate Professor of Urology at Yale, on the clinical utility of PSMA imaging.
View More
Benefits of PSMA-PET for High-Risk/Advanced Prostate Cancer: Part 2
GU Oncology Now Editors
RLT
|
December 1, 2022
Part two of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
View More
Benefits of PSMA-PET for High-Risk/Advanced Prostate Cancer: Part 1
GU Oncology Now Editors
RLT
|
November 27, 2024
Part one of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
View More
Using PSMA-PET to Better Understand Recurrence Risk and Inform Therapy Plans: Part 2
Akhil Abraham Saji, MD
RLT
|
December 2, 2022
Dr. Saji continues his interview with Dr. Sonni about using PSMA-PET to understand recurrence risk and inform therapy plans.
View More
Using PSMA-PET to Better Understand Recurrence Risk and Inform Therapy Plans: Part 1
Akhil Abraham Saji, MD
RLT
|
December 2, 2022
Akhil Saji, MD, interviews Ida Sonni, MD, about using PSMA-PET to better understand recurrence risk and inform therapy plans.
View More
Scott Tagawa, MD, on PSMA PET-CT and its Utility in Prostate Cancer - Part 1
GU Oncology Now Editors
RLT
|
December 1, 2022
Dr. Tagawa discusses how PSMA is used in the detection of prostate cancer, the approval of gallium-68 PSMA PET-CT, and more.
View More
Scott Tagawa, MD, on PSMA PET-CT and its Utility in Prostate Cancer - Part 2
GU Oncology Now Editors
RLT
|
December 1, 2022
Dr. Tagawa discusses clinical trials he's watching for, using PSMA for an initial prostate cancer diagnosis, and more.
View More
Dr. Amar Kishan Discusses the Impact of Precision Medicine & PSMA Imaging in Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Dr. Kishan discusses PSMA-directed imaging and the impact of precision medicine on the treatment of advanced prostate cancer.
View More
PSMA PET Imaging Modalities a "Game Changer" in Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Drs. Lenzo and Singh discuss the impact PSMA PET modalities have had in the fight against advanced prostate cancer.
View More
Next Generation Imaging for Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Panel participants discuss PSMA and PSMA PET-based scans for diagnosis and management of patients with prostate cancer.
View More
Dr. Jeremie Calais Discusses the Current Status of PSMA Diagnostics
Robert Dillard
RLT
|
December 2, 2022
Dr. Jeremie Calais discusses the future of PSMA PET imaging modalities in prostate cancer with Dr. Agarwal.
View More
PSMA Imaging: The Future of Traditional CT Scans
GU Oncology Now Editors
RLT
|
February 28, 2023
Drs. Agarwal and Tagawa discuss PSMA imaging and the future of CT scans in the follow-up of metastatic prostate cancer.
View More
PSMA Imaging: Integration Into Urologic Oncology
GU Oncology Now Editors
RLT
|
February 28, 2023
Drs. Agarwal and Tward discuss the use of PSMA imaging for oncologists and urologists dealing with localized prostate cancer.
View More
PSMA Imaging: What It Is and How It’s a Game-Changer
GU Oncology Now Editors
Roundtable
|
February 28, 2023
Drs. Agarwal and Calais review the basics of PSMA imaging of prostate cancer and what makes it unique.
View More
Dr. Delphine Chen On Using PSMA PET Modalities to Detect Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Dr. Delphine Chen discusses the use of PSMA-targeted PET imaging modalities for detecting prostate cancer.
View More
Dr. R. Jeffrey Karnes on the Benefits of PSMA Imaging in Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Dr. Karnes explains why he believes the PSMA scan is a game changer for prostate cancer detection and its benefits.
View More
Dr. Thomas Hope on the Clinical Benefits of PSMA Imaging in Prostate Cancer
Robert Dillard
RLT
|
December 2, 2022
Dr. Hope provides expert insight on using PSMA imaging for the staging and management of prostate cancer.
View More
Dr. Stefano Fanti on the Importance of PSMA-PET Imaging in Prostate Cancer
Robert Dillard
RLT
|
December 1, 2022
Dr. Fanti discusses an article he co-authored on imaging technologies for men with rising prostate-specific antigen.
View More
Advertisement
Advertisement
Advertisement
Advertisement